Evidence map›Paper›PMID 38988282›Full record

ArticleJournal of diabetes investigation2024

A consensus statement from the Japan Diabetes Society: A proposed algorithm for pharmacotherapy in people with type 2 diabetes - 2nd edition (English version).

Ryotaro Bouchi, Tatsuya Kondo, Yasuharu Ohta, Atsushi Goto, Daisuke Tanaka, Hiroaki Satoh, Daisuke Yabe, Rimei Nishimura, Norio Harada, Hideki Kamiya and 3 more

Abstract readConsensus Statement
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of diabetes investigation, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Ryotaro BouchiDiabetes and Metabolism Information Center, Diabetes Research Center, National Center for Global Health and Medicine, Tokyo, Japan.ORCID https://orcid.org/0000-0002-7664-4342
Tatsuya KondoDepartment of Diabetes, Metabolism and Endocrinology, Kumamoto University Hospital, Kumamoto, Japan.
Yasuharu OhtaDivision of Endocrinology, Metabolism, Hematological Sciences and Therapeutics, Yamaguchi University Graduate School of Medicine, Yamaguchi, Japan.
Atsushi GotoDepartment of Health Data Science, Graduate School of Data Science, Yokohama City University, Yokohama, Japan.
Daisuke TanakaDepartment of Diabetes, Endocrinology and Nutrition, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
Hiroaki SatohDepartment of Diabetes and Endocrinology, Juntendo University Urayasu Hospital, Chiba, Japan.
Daisuke YabeDepartment of Diabetes, Endocrinology and Metabolism and Department of Rheumatology and Clinical Immunology, Gifu University Graduate School of Medicine, Gifu, Japan.
Rimei NishimuraDivision of Diabetes, Metabolism and Endocrinology, Jikei University School of Medicine, Tokyo, Japan.
Norio HaradaDepartment of Diabetes, Endocrinology and Nutrition, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
Hideki KamiyaDivision of Diabetes, Department of Internal Medicine, Aichi Medical University, Nagakute, Japan.
Ryo SuzukiDepartment of Diabetes, Metabolism and Endocrinology, Tokyo Medical University, Tokyo, Japan.
Toshimasa YamauchiDepartment of Diabetes and Metabolic Diseases, University of Tokyo Graduate School of Medicine, Tokyo, Japan.
JDS Committee on Consensus Statement Development

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This algorithm was issued for the appropriate use of drugs for the treatment of type 2 diabetes mellitus in Japan. The revisions include safety considerations, fatty liver disease as a comorbidity to be taken into account and the position of tirzepatide.

Indexed as

AlgorithmsConsensusDiabetes Mellitus, Type 2Hypoglycemic AgentsHumansJapanSocieties, MedicalHypoglycemic AgentsAlgorithmPharmacotherapyType 2 diabetes

Identifiers

PMID38988282
PMCPMC11363114

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.